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cial cost to an institution from unreimbursed charges,
there is great interest in identifying ways to minimize
these infections. Interventions should target modifiable
surgical or patient risk factors and infection control
practices. Several reports have described risk factors for
DSSI after median sternotomy. Some of the host risk
factors identified include sex,4,6 age,4,10 obesity,2-4,8,11,12
poor functional cardiac status,10 low cardiac output
state,9 diabetes mellitus,3,5,12 elevated postoperative
blood glucose levels,8 and preoperative Staphylococcus
aureus nasal carriage.13 Surgical risk factors identified
include prolonged duration of the operation,2,9 postop-
erative bleeding,9,14 repeat cardiac operation,9,14,15
bilateral internal thoracic artery harvest,2,11 and indis-
criminate use of electrocautery.16 Despite identification
of risk factors for infection, modification of many of
these risk factors can be difficult or impossible.
However, intervention is possible in some host and sur-
gical risk factors, and some infection control principles
are available that should minimize bacterial contamina-
tion during the operation.
I n the United States, more than 450,000 coronaryartery bypass graft (CABG) procedures are performed
each year.1 Deep sternal site infection (DSSI) is a com-
plication of CABG surgery associated with substantial
morbidity and with mortality as high as 14%.2,3 In addi-
tion, a DSSI has been estimated to increase the cost of
each operation nearly 3-fold.2 Several recent reports
document DSSI prevalence between 0.7% and
3.9%.2,4-9 Because of high patient morbidity and mor-
tality associated with post-CABG DSSI and the finan-
Objective: Our objective was to identify risk factors for deep sternal site
infection after coronary artery bypass grafting at a community hospital.
Methods: We compared the prevalence of deep sternal site infection
among patients having coronary artery bypass grafting during the study
(January 1995–March 1998) and pre-study (January 1992–December
1994) periods. We compared any patient having a deep sternal site infec-
tion after coronary artery bypass graft surgery during the study period
(case-patients) with randomly selected patients who had coronary
artery bypass graft surgery but no deep sternal site infection during the
same period (control-patients). Results: Deep sternal site infections were
significantly more common during the study than during the pre-study
period (30/1796 [1.7%] vs 9/1232 [0.7%]; P = .04). Among 30 case-
patients, 29 (97%) returned to the operating room for sternal debride-
ment or rewiring, and 2 (7%) died. In multivariable analyses, cefurox-
ime receipt 2 hours or more before incision (odds ratio = 5.0), diabetes
mellitus with a preoperative blood glucose level of 200 mg/dL or more
(odds ratio = 10.2), and staple use for skin closure (odds ratio = 4.0) were
independent risk factors for deep sternal site infection. Staple use was a
risk factor only for patients with a normal body mass index. Conclusions:
Appropriate timing of antimicrobial prophylaxis, control of preopera-
tive blood glucose levels, and avoidance of staple use in patients with a
normal body mass index should prevent deep sternal site infection after
coronary artery bypass graft operations. (J Thorac Cardiovasc Surg
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From January 1995 through March 1998 (study peri-
od), personnel at Saint Marys Hospital Medical Center
(SMHMC), Madison, Wisconsin, detected an increas-
ing prevalence of post-CABG DSSI, that is, sternal
osteomyelitis or mediastinitis (Fig 1). In addition, the
DSSI prevalence during the study period at SMHMC
(1.7%) was higher than the Centers for Disease Control
and Prevention’s (CDC) National Nosocomial
Infections Surveillance (NNIS) system pooled mean
rate for 1992 through 1997 of 0.65%. Despite efforts at
SMHMC to reduce the DSSI prevalence, the preva-
lence remained higher than the NNIS system rate. To
formulate an intervention to prevent post-CABG DSSI,
we evaluated CABG procedures at SMHMC, collected
data on all measurable, previously reported risk factors,
and selected potential risk factors not previously
reported.
Patients and methods
Background. SMHMC is a 350-bed community hospital.
From 1995 through 1997, cardiothoracic surgeons at
SMHMC performed approximately 530 CABG procedures
per year. The majority of operations were performed in one of
three operating rooms; two of these are used almost exclu-
sively for CABG procedures, and the third operating room
also was used for other vascular procedures. There was no
cardiothoracic house staff at SMHMC, and all of the cardio-
thoracic surgeons operated exclusively at SMHMC.
Case definition and study period. A case-patient was
defined as any patient who had undergone a CABG proce-
dure at SMHMC during the study period and subsequently
had a deep incisional or organ/space DSSI as defined by the
CDC.17 To verify that the post-CABG DSSI prevalence had
significantly increased, we compared the post-CABG DSSI
prevalence (ie, the number of post-CABG DSSIs divided by
the total number of CABG procedures performed by median
sternotomy) in the study and pre-study periods (January 1992
through December 1994.
Case ascertainment and control selection. All case-
patients had been identified during surveillance by infection
control personnel at SMHMC. Surveillance at SMHMC
included regular review of inpatients who had undergone a
CABG procedure, review of microbiology laboratory culture
results, notification of infection control practitioners at
SMHMC by an outpatient clinic physician or nurse, and eval-
uation of patients readmitted after CABG operations.
Medical records of case-patients were reviewed to verify that
the case definition criteria were met. Control-patients (n =
90) were randomly selected in a 3:1 ratio from the population
of patients who had a CABG procedure performed by medi-
an sternotomy during the study period but did not acquire a
DSSI.
Case-control study. To identify exposures associated with
DSSI, we reviewed the medical records of case-patients and
control-patients. Preoperative variables examined included
the following: American Society of Anesthesiologists (ASA)
classification; blood glucose level (obtained within 24 hours
before the operation); body mass index [BMI (kilograms per
square meter)]; diagnosis; duration of hospitalization; left
Fig 1. Prevalence of post-CABG DSSI at St Marys Hospital Medical Center (SMHMC), Madison, Wisconsin,
January 1, 1992, through March 31, 1999. *Data were available for the first two quarters of 1999.
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ventricular ejection fraction; steroid receipt (as recorded in
the preoperative assessment); tobacco use; and urgency of the
procedure (elective, urgent, or emergency). Intraoperative
variables examined included the following: associated proce-
dure(s); volume of blood retrieved from the cell salvage sys-
tem; day of the week on which the procedure was performed;
duration of hypothermia (temperature < 35°C); NNIS surgi-
cal risk index; operating room number; operating room per-
sonnel; perfusion, pump, and aortic crossclamp times (min-
utes); prophylactic antimicrobial agent administered and the
timing and duration of administration; source and number of
grafts; temporary pacemaker placement; and type of skin clo-
sure (ie, staple or suture closure). The following postopera-
tive variables were examined: antimicrobial use; blood glu-
cose level (average of peak glucose levels for the first 7 days
after the operation); duration of chest tube placement; dura-
tion of prophylactic antimicrobial receipt; number of red
blood cell units transfused; severity of illness 24 hours after
the operation, as measured by the Therapeutic Intervention
Scoring System (TISS)18; and volume of chest tube output.
Procedure review/observational studies. We reviewed
the preoperative skin preparation protocol and practice on
inpatients and early morning admissions. We observed oper-
ating room skin preparation and patient draping. To monitor
for breaks in sterile technique, we observed several CABG
procedures, including saphenous vein, internal thoracic artery,
and radial artery graft harvests. We toured the surgical inten-
sive care unit and reviewed protocols for incision site care.
Statistical methods. Data were collected on a standardized
form, entered, and analyzed with the CDC’s Epi Info version
6.03 software. We analyzed several continuous variables after
creating dichotomous variables using the following cutoff
Table I. Comparison of risk factors among case-patients and control-patients at Saint Marys Hospital Medical
Center, Madison, Wisconsin, January 1995 through March 1998
Case-patients Control-patients Odds ratio 
Variable (n = 30) (n = 90) (95% CI) P value
Categoric variables, No. (%)
Staples for chest skin closure 18 (60) 29 (32) 3.2 (1.2-8.2) .007
Bilateral ITA graft 4 (13) 1 (1) 14 (1.3-342) .01
Diabetes mellitus receiving insulin 8 (27) 8 (8) 3.7 (1.1-13) .01
Diabetes mellitus 17 (57) 30 (33) 2.6 (1.0-6.7) .02
Preoperative glucose ≥ 200 mg/dL* 9/15 (60) 6/26 (23) 5.0 (1.0-26) .02
Cefuroxime receipt ≥ 2 h before incision or 14/24 (58) 23/72 (32) 3.0 (1.0-8.7) .02
after operation*†
Cefuroxime receipt ≥ 2 h before incision*† 12/22 (55) 20/69 (29) 2.9 (1.0-9.0) .03
Antimicrobial receipt ≥ 2 h before incision or 16/28 (57) 31/87 (36) 2.4 (0.9-6.3) .04
after operation*
COPD 4 (13) 5 (6) 2.6 (0.5-13) .16
ASA score > 3 19 (63) 44 (49) 1.8 (0.7-4.6) .17
Obese (BMI ≥ 30)* 13/29 (45) 26/84 (31) 1.8 (0.7-4.8) .18
Chest tube removed after POD 2 16 (53) 36 (40) 1.7 (0.7-4.3) .20
Repeat CABG 5 (17) 9 (10) 1.8 (0.5-6.7) .32
LVEF ≤ 40%* 7/29 (24) 13/82 (16) 1.7 (0.5-5.4) .32
Hospitalization before procedure 18 (60) 58 (64) 0.8 (0.3-2.1) .83
Another procedure concurrent with CABG 3 (10) 10 (11) 0.9 (0.2-3.9) 1.0
Continuous median (interquartile-range)
Pulmonary artery diastolic pressure (mm Hg) 20 (17-26) [n = 27] 16 (14-21) [n = 81] .01
Glucose level before operation (mg/dL) 225 (158-275) [n = 15] 158 (121-180) [n = 26] .02
Glucose level after operation (mg/dL) 262 (241-295) [n = 17] 244 (208-274) [n = 30] .04
Duration of hypothermia (min) 70 (45-92) 59 (35-87) .34
Volume in cell salvage system (mL) 955 (800-1200) 900 (810-1125) .57
Preoperative hospitalization (d) 3.0 (1.0-6.0) 4.0 (2.0-6.0) .72
Age (y) 66 (59-72) 65 (58-73) .87
Clamp time (min) 81 (63-103) 86 (69-106) .87
Pump time (min) 119 (94-149) 120 (94-148) .89
No. of CABGs 3.0 (2.0-5.0) 3.0 (3.0-5.0) .92
Duration of operation (min) 252 (220-294) 244 (205-303) .95
TISS score 35 (35-39) 35 (35-38) .99
CI, Confidence interval; ITA, internal thoracic artery; COPD, chronic obstructive pulmonary disease; ASA, American Society of Anesthesiology; BMI, body mass
index; POD, postoperative day; CABG, coronary artery bypass graft; LVEF, left ventricular ejection fraction; TISS, Therapeutic Intervention Scoring System.
*Patients for whom data were missing were excluded from these analyses. Denominators are displayed for these variables.
†Includes only patients who received cefuroxime.
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values: BMI more than 30 kg/m2, blood glucose level 200
mg/dL or more, left ventricular ejection fraction more than
40%, and initiation of cefuroxime antimicrobial prophylaxis
120 minutes or more before skin incision. During logistic
regression analyses, patients were classified into one of the
following mutually exclusive categories: no diagnosis of dia-
betes mellitus, diabetes mellitus with a preoperative blood
glucose level less than 200 mg/dL, and diabetes mellitus with
a preoperative blood glucose level of 200 mg/dL or more.
Categoric variables were compared with the use of either
the Fisher exact test or χ2 test. Odds ratios and 95% confi-
dence intervals were calculated. Continuous variables were
compared with the use of the Kruskal-Wallis test for non-
parametric data. Mantel-Haenszel summary odds ratios and
95% confidence intervals were calculated for all stratified
analyses. To identify independent risk factors, we construct-
ed a logistic regression model using SAS for personal com-
puters (SAS Institute, Cary, NC). All variables with P < .1 by
univariate analysis were evaluated by stepwise logistic
regression for inclusion in the final model.
Results
DSSI prevalence and case-patient characteristics.
The DSSI prevalence was significantly higher in the
study than in the pre-study period (30/1796 [1.7%] vs
9/1232 [0.7%]; P = .04). Thirty patients met the case
definition. Case-patients had a median age of 66 years
(range 59-72 years), 22 (73%) were male, 17 (57%)
had diabetes mellitus, 13 (43%) were obese, and 29
(97%) returned to the operating room for sternal
rewiring or sternal debridement. The median incuba-
tion period was 15 days (range 7-161 days). In 10 case-
patients (33%) DSSI was diagnosed during the same
admission in which the CABG operation was per-
formed, and in 20 (67%) the diagnosis was made after
readmission to the hospital. The median duration of
hospitalization for patients readmitted with DSSI was
16 days (range 4-74 days). Twelve (40%) case-patients
required sternal reconstruction with muscle flaps, and 2
(6.7%) died during the hospitalization for DSSI.
Culture-positive specimens were obtained from the
DSSI in 27 case-patients; pathogens included Staphylo-
coccus epidermidis (n = 12, 44%), S. aureus (n = 4,
15%), Pseudomonas aeruginosa (n = 2, 7%), entero-
coccus (n = 1, 4%), and polymicrobial infections (n =
8, 30%). In 3 case-patients no organism was isolated.
Case-control study. The median duration of postop-
erative hospitalization for case-patients in whom DSSI
was diagnosed during the surgery admission (n = 10)
was significantly longer than the duration for 90 con-
trol-patients: 28 versus 6 days (P < .001). In univariate
analysis, case-patients and control-patients were simi-
lar with regard to the following criteria: age; ASA clas-
sification; sex; hospitalization before the operation;
duration of preoperative stay; NNIS risk index; repeat
CABG; type of graft (except bilateral internal thoracic
artery); number of grafts; placement of temporary
pacemaker; duration of chest tube placement; operating
room; incision time; obesity; surgeon; duration of oper-
ation, pump or clamp time, and hypothermia; volume
from the cell salvage system; TISS score; and volume
of chest tube output. In contrast, case-patients were sig-
nificantly (P < 0.05) more likely than control-patients
to have had bilateral internal thoracic artery harvest,
staples used for skin closure, diabetes mellitus (with
and without insulin use), glucose level of 200 mg/dL or
more before the operation, higher blood glucose levels
before and after the operation, and a higher pulmonary
artery diastolic pressure (Table I).
Of 119 patients who had documented antimicrobial
prophylaxis, all received antimicrobial prophylaxis
with either cefuroxime (n = 100) or vancomycin (n =
19). Receipt of the prophylactic antimicrobial agent
120 minutes or more before skin incision was signifi-
cantly associated with DSSI. Since cefuroxime and
vancomycin have different pharmaceutical half-lives,
we also evaluated timing of antimicrobial receipt for
the subset of patients who had received cefuroxime as
the prophylactic antimicrobial agent. Receipt of
cefuroxime 120 minutes or more before skin incision
was significantly associated with DSSI (Table I).
We present two final logistic regression models
(Tables II and III). Model 1 (Table II) included signifi-
cant variables identified in the stepwise logistic regres-
sion analysis: staple use for skin closure, diabetes mel-
litus categorized as described in the “Patients and
methods” section, and prophylactic antimicrobial agent
Table II. Independent risk factors for post-CABG
DSSI at Saint Marys Hospital Medical Center, Madison,
Wisconsin, January 1, 1995, through March 31, 1998
Odds ratio 
Variable (95% CI) P value
Staples used for chest skin closure
No 1.0 —
Yes 4.0 (1.4-12) .01
Diabetes mellitus
No 1.0 —
Yes, preoperative glucose < 200 mg/dL 1.4 (0.4-4.8) .6
Yes, preoperative glucose ≥ 200 mg/dL 10.2 (2.4-43) .008
Antimicrobial receipt
Cefuroxime < 2 h before incision 1.0 —
Cefuroxime ≥ 2 h before incision 5.0 (1.4-17) .002
Vancomycin receipt 4.2 (0.9-20) .07
CI, Confidence interval.
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and timing of administration. Independent risk factors
identified by multivariable analysis were skin closure
with staples, diabetes mellitus with a preoperative glu-
cose level of 200 mg/dL or more, or cefuroxime receipt
2 hours or more before the operation (Table II). Diabetes
mellitus with a preoperative blood glucose level less than
200 mg/dL was not associated with DSSI.
Because staple use for skin closure has not previous-
ly been identified as a risk factor for post-CABG DSSI,
we attempted to identify confounding variables. We
performed stratified analyses with staple use and mul-
tiple previously identified risk factors (eg, duration of
the operation, urgency of the procedure, BMI, and ASA
classification). The interaction of staple use and BMI
was statistically significant (P = .03). We used logistic
regression (model 2) to evaluate staple use in patients
stratified by BMI. Model 2 also included diabetes mel-
litus and antimicrobial receipt as categorized in model
1. Staple use for skin closure was associated with DSSI
only in patients who had a normal BMI (Table III).
Skin preparation procedure review. For inpatients,
the skin preparation protocol before CABG surgery
included an antiseptic scrub, suppository insertion, hair
removal by clipping, and a repeat antiseptic scrub, all
performed the night before the operation. No repeat
morning scrub was administered. For patients admitted
the same day as the operation, a similar protocol was
followed but performed the morning of the operation.
For the majority of patients, hair removal by clipping
was performed, regardless of sex.
Discussion
Using CDC surveillance methods, personnel at
SMHMC identified a high prevalence of post-CABG
DSSI. A detailed investigation revealed three indepen-
dent risk factors, all of which are potentially modifi-
able: preoperative hyperglycemia, administration of
cefuroxime prophylaxis 2 hours or more before skin
incision, and skin closure with staples among patients
with a normal BMI.
Diabetes mellitus3,5,12 and elevated postoperative
blood glucose levels8 have been identified as risk fac-
tors for DSSI. Our data suggest that diabetes mellitus is
a risk factor only when the preoperative blood glucose
level is 200 mg/dL or higher. Elevated blood glucose
levels (eg, glucose > 200 mg/dL) have been associated
with increased infection among persons with dia-
betes,19 and specific detrimental effects of such levels
on the host immune system have been described.20
Optimal immune system function at the time of the
operation, when risk of contamination is increased,
may be critical to prevention of DSSI. Improvements in
preoperative metabolic factors (eg, blood glucose lev-
els) are necessary to optimize immune system function.
There is evidence that improved glucose control in
patients with diabetes may improve immune system
function,21 and one study reported a decrease in DSSI
after initiation of a protocol to reduce postoperative
blood glucose levels to less than 200 mg/dL.8 An alter-
native hypothesis is that prolonged elevation of glucose
results in end organ damage that may be associated
with increased risk for DSSI. Since suboptimal
glycemic control has been correlated with end organ
dysfunction,22,23 it may be difficult to determine the
relative contribution of hyperglycemia in the immedi-
ate preoperative period versus the detrimental effects of
prolonged hyperglycemia. One possibility would be to
compare glycosylated hemoglobin values, end organ
dysfunction (eg, retinopathy, nephropathy, or neuropa-
thy), and blood glucose levels before the operation as
risk factors for DSSI. Unfortunately, in our study, gly-
cosylated hemoglobin values were not available for the
majority of patients. To our knowledge, improved glu-
cose control before surgery has not been shown to
decrease the risk of infection after the operation; how-
ever, because of the association of increased blood glu-
Table III. Evaluation of the interaction between staple use for skin closure and body mass index (BMI),* Saint
Marys Hospital Medical Center, Madison, Wisconsin, January 1, 1995, through March 31, 1998
Case-patients‡ Control-patients‡ Odds ratio§
Staples BMI† [n = 29] (%) [n = 85] (%) (95% CI) P value
No Normal 4 (14) 42 (49) 1.0 —
No High 8 (28) 16 (19) 4.8 (0.8-30) .1
Yes High 5 (17) 10 (12) 4.4 (0.6-34) .15
Yes Normal 12 (41) 17 (20) 13.5 (2.3-79) .004
*The interaction of staples used for skin closure and BMI was statistically significant.
†High BMI, > 30 kg/m2; normal BMI, ≤ 30 kg/m2.
‡Case-patients and control-patients who had BMI recorded (n = 114).
§Values determined in a logistic regression model that included diabetes mellitus and antimicrobial receipt (as per Table II).
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cose levels and infection and the probability of
improved immune system function with a decrease in
blood glucose level, it is prudent to lower blood glucose
levels (<200 mg/dL) in patients about to undergo
CABG operations.
Although the optimal time for preoperative receipt of
antimicrobial prophylaxis among patients about to
undergo varied surgical procedures has been
described,24 we know of no reports that confirm this
finding in the CABG surgery population. Cefuroxime
has a shorter pharmaceutical half-life than vancomycin;
therefore, early dosing of cefuroxime may result in rel-
atively low blood and tissue concentrations at the time
of surgery. Appropriate timing of administration likely
is more critical if cefuroxime is given as the prophylac-
tic antimicrobial agent.
We analyzed timing of cefuroxime receipt indepen-
dent of vancomycin receipt. We compared cefuroxime
receipt 2 hours or more before the operation (early
antimicrobial prophylaxis) with cefuroxime receipt less
than 2 hours before incision. We found that those
patients receiving early cefuroxime antimicrobial pro-
phylaxis had an increased risk of DSSI. Vancomycin
receipt was associated with DSSI, but the result may
have been due to chance. In addition, we included van-
comycin in our analysis as a single risk factor regard-
less of “appropriate” or “inappropriate” timing of
administration. Since several patients received van-
comycin 120 minutes or more before skin incision, we
cannot make any conclusions about vancomycin and
cefuroxime as prophylactic antimicrobial agents before
CABG operations.
Staple use for skin closure has not previously been
reported as a risk factor for post-CABG DSSI. In our
multivariable analysis controlling for potential con-
founders, we found that staple use was a risk factor
only in patients with a normal BMI. One possible
explanation is that staple depth in non-obese patients in
a region with relatively little subcutaneous tissue may
increase the possibility of microbial invasion to
anatomically deeper tissue planes, resulting in DSSI.
We acknowledge that a retrospective study design is
suboptimal for determining causality and that unmea-
sured characteristics may have influenced these results.
However, after literature review, we collected data on
all previously reported measurable risk factors. In addi-
tion, contrary to previous studies, we found no associ-
ation between obesity and DSSI.
Limitations of this investigation included the inabili-
ty to obtain complete data for all variables.
Specifically, glucose levels were not available for all
patients with diabetes, and pulmonary artery catheters
were not placed in all patients. Another possible limita-
tion was that glycosylated hemoglobin values were not
available. Although glycosylated hemoglobin would
more accurately reflect glucose control over a longer
preoperative period of time, a single glucose level
before the operation likely represents glucose control
immediately preceding surgery.
The high morbidity and mortality of post-CABG
DSSI detected in previous studies2,3,5,15 also was
detected in our study. Consistent with other studies,5,13
we detected a significantly longer length of stay for
those patients who had a DSSI. Therefore, in addition
to the catastrophic human consequences, there is sig-
nificant economic impact on patients and/or hospitals
as a result of post-CABG DSSI.
The human and economic impact of DSSI is a com-
pelling reason to evaluate and change hospital policies
and practices that may be contributing to DSSI. Several
interventions are likely to be beneficial in preventing
DSSI, and the solutions often require a multidiscipli-
nary approach. Improved preoperative glucose control
will require coordination between cardiothoracic sur-
geons, cardiologists, primary care physicians, and
endocrinologists. Appropriate timing of antimicrobial
prophylaxis requires coordination between cardiotho-
racic surgeons and anesthesiologists. The association
of staple use for skin closure in patients with a normal
BMI is intriguing and plausible; however, it requires
validation in a larger study. Together, these interven-
tions could help decrease the risk of post-CABG DSSI
and reduce overall morbidity and mortality.
We acknowledge L. Douglas Cowgill, MD, and Vijay
Kantamneni, MD, for their contributions during the study and
preparation of the manuscript.
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